Tous Actualités
Suivre
Abonner Korian Deutschland AG

Korian Deutschland AG

EANS-Adhoc: CURANUM AG
Financial Figures 2009

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
31.03.2010
Ad hoc announcement
CURANUM AG publishes 2009 results
Occupancy stable in 2009, revenue and EBITDA budgets achieved
CURANUM AG, Munich, announces  its  results  for  the  2009  
financial  year  at today's results press conference and analyst 
meeting in Frankfurt. The  capacity utilization of care beds and 
managed apartments was stable in 2009, albeit at  a somewhat lower 
average level than in 2008.
Revenue rose by 1.0% from EUR 257.1 million in  2008  to  EUR 259.5  
million  in 2009, an increase of EUR 2.4 million. We thereby  
exceeded  our  revenue  budget (EUR 257.0 million to EUR 259.0 
million). The increase was due to  revenue  from our new Scheffelhof 
senior  residence  in  Bad  Dürrheim,  the  senior  citizen residence
and care facility in Braunschweig,  as  well  as  additional  
revenues from our outpatient service in Coburg, and  from  care  
services  for  occupants suffering dementia.
Rental expenses rose by EUR 0.9 million or 1.65% to EUR 55.5  million
(previous year: EUR 54.6 million). This was mainly due to the rental 
indexations  of  the properties we rent. Staff costs increased  by  
EUR 2.7  million  or  2.1%,  from EUR 127.8 million in 2008 to 
EUR 130.5 million in 2009.
As a consequence, earnings before interest, tax, depreciation, 
amortization  and rents (EBITDAR) amounted to EUR 83.1 million in 
2009  (previous  year:  EUR 83.9 million), reflecting a decline of 
EUR 0.8 million  or  0.95%  year-on-year.  The EBITDAR margin stood 
at 32.0% (previous year: 32.6%), which  represents  a  peak outcome 
on a European peer group comparison.
EBITDA earnings declined from EUR 29.3 million in 2008 to  EUR 27.6  
million  in 2009, which corresponds to an EBITDA margin of 10.64% in 
this  reporting  period (previous year: 11.4%).
Compared with  the  previous  year,  depreciation  and  amortization 
rose  only slightly from EUR 9.5 million in 2008 to EUR 9.8 million 
in  2009,  representing an increase of EUR 0.3 million or  3.16%.  As
a  consequence,  earnings  before interest and tax (EBIT) amounted to
EUR 17.8 million  (previous  year:  EUR 19.7 million), reflecting an 
EBIT margin of 6.86% in 2009 (previous year: 7.66%).
The tax rate increased in 2009. Consequently, income tax and deferred
tax  were around EUR 0.7 million higher than budgeted. At EUR 5.8 
million (previous  year: EUR 7.0 million) we failed to achieve our 
budgeted post-tax earnings of  EUR 6.5 million - EUR 8.5 million. 
Earnings per share amounted to EUR 0.18 in  the  2009 reporting 
period (previous year: EUR 0.22).
Cash flow from operating activities  rose  slightly  from  EUR 19.8  
million  to EUR 19.9 million as of the end of 2009, and  the  cash  
outflow  from  investing activities dropped from EUR 18.7 million to 
EUR 5.2 million in 2009.  Cash  flow from  financing  activities  was
again  characterized  by  the  redemption   of financial liabilities 
in an amount of EUR 5.6 million  (previous  year:  EUR 4.9 million), 
outgoing payments for finance leasing  of  EUR 7.8  million  
(previous year: EUR 7.6 million), as well as the dividend payment at 
the  previous  year's level at EUR 3.2 million.
The full results for the 2009 financial year are available  on  our  
website  at www.curanum.de in the Investor Relations area.
Munich, March 31, 2010
The Management Board
|Key figures IFRS as of December 31,    |           |                |
|2009                                   |           |                |
|                               |       |           |                |
|                               |       |           |                |
|mil.  EUR                      |2009   |2008 1)    |YOY in %        |
|                               |       |           |                |
|Sales                          |259.5  |257.1      |0.93            |
|Staff costs                    |130.5  |127.8      |2.11            |
|EBITDAR                        |83.1   |83.9       |-0.95           |
|Rental costs                   |55.5   |54.6       |1.65            |
|EBITDA                         |27.6   |29.3       |-5.80           |
|in % of Sales                  |10.6%  |11.4%      |                |
|Depreciation                   |9.8    |9.5        |3.16            |
|EBIT                           |17.8   |19.7       |-9.64           |
|in % of Sales                  |6.9%   |7.7%       |                |
|Financial results              |-8.9   |-9.5       |-6.32           |
|EBT                            |8.9    |10.2       |-12.75          |
|Net profit                     |5.8    |7.0        |-17.14          |
|EPS (EUR) *)                   |0.18   |0.22       |-18.18          |
|                               |       |           |                |
|Cashflow                       |19.9   |19.8       |0.51            |
|CPS (EUR) *)                   |0.62   |0.61       |1.64            |
|                               |       |           |                |
|Cash and cash equivalents      |8.9    |10.0       |-11.00          |
|Equity capital                 |66.1   |64.1       |3.12            |
|in % of balance sheet total    |28.0%  |27.0%      |                |
|Balance sheet total            |236.4  |237.7      |-0.55           |
|                               |       |           |                |
|Employees                      |6,055  |5,953      |1.71            |
|Facilities                     |69     |68         |1.47            |
|Care places                    |7,805  |7,708      |1.26            |
|Assisted living apartements    |1,681  |1,638      |2.63            |
|                               |       |           |                |
|*) Number of unterlying outstanding    |           |                |
|shares in 2009: 32,267,835 shares      |           |                |
|*) Number of underlying outstanding    |           |                |
|shares in 2008: 32,611,091 shares      |           |                |
|1) restated in 2009                    |           |                |
end of announcement                               euro adhoc

Further inquiry note:

Marion Mühlschlegel

Tel. +49 (0)89 242065-68

Email marion.muehlschlegel@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: SDAX, CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing

Plus de actualités: Korian Deutschland AG
Plus de actualités: Korian Deutschland AG
  • 12.11.2009 – 08:35

    EANS-Adhoc: CURANUM AG / Publishing the results of Q3/ 2009

    ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. quarterly report 12.11.2009 Ad hoc announcement EUR 7.5 million of EBITDA in the third quarter of 2009 CURANUM AG, Munich, raised consolidated revenue from EUR 65.0 million in the third quarter of 2008 to EUR 65.7 ...

  • 13.08.2009 – 08:35

    EANS-Adhoc: CURANUM AG / Figures Q2-2009/ HY1 2009

    ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 6-month report/Figures Q2-2009 / HY1 2009 13.08.2009 Ad hoc announcement Second-quarter revenue within budget CURANUM AG, Munich, achieved revenue of EUR 64.3 million in the second quarter of 2009. This represents an ...

  • 05.08.2009 – 15:59

    EANS-News: CURANUM AG / New CFO at CURANUM

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. companies/New CFO at CURANUM München (euro adhoc) - [pic] Press release New CFO at CURANUM The Supervisory Board of CURANUM AG, Munich, one of the largest private care facility operators in Germany, has appointed Judith Barth (38) as the company's new CFO with immediate ...